Literature DB >> 18500685

Prostatic inflammation and obstructive voiding in the adult Noble rat: impact of the testosterone to estradiol ratio in serum.

Jenni Bernoulli1, Emrah Yatkin, Yvonne Konkol, Eva-Maria Talvitie, Risto Santti, Tomi Streng.   

Abstract

BACKGROUND: The age-related decline of the testosterone to estradiol (T-to-E(2)) ratio in serum is associated with the increased prevalence of prostatic inflammation and lower urinary tract symptoms suggesting obstructive voiding. The impact of the T-to-E(2) ratio on the development and reversal of non-bacterial prostatic inflammation and obstructive voiding was tested in adult Noble rats.
METHODS: Adult male Noble rats (n = 16) were treated with estradiol (83 microg/day) and two different doses (280 and 830 microg/day) of testosterone to cause hypoandrogenic and hyperandrogenic states with elevated estrogen. After the 13-week hormonal treatment, urodynamical measurements and electrical activity recording of the rhabdosphincter muscle were performed under anesthesia. Testosterone, estradiol, and prolactin concentrations in serum were measured and inflammatory changes in the dorsolateral prostate were classified and counted.
RESULTS: Histopathological and urodynamical analyses indicated that the hypoandrogenic animals with a decreased T-to-E(2) ratio (10 versus > 300 in control) developed prostatic inflammation and non-obstructive voiding. The hyperandrogenic state with decreased T-to-E(2) ratio of 50 decreased the aggressiveness of the inflammation and the number of inflamed acini in the prostate and caused urethral obstruction associated with rhabdosphincter dysfunction.
CONCLUSIONS: Different responses of the prostatic inflammation and voiding function to the change in T-to-E(2) ratio imply that non-bacterial prostatic inflammation is not a sufficient condition for the development of obstructive voiding. The present study finds no support for the idea that age- and/or obesity-related hypoandrogenic state with a decreased ratio of T-to-E(2) would cause urethral obstruction. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18500685     DOI: 10.1002/pros.20791

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  32 in total

Review 1.  Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Authors:  Shuk-Mei Ho; Ming-Tsung Lee; Hung-Ming Lam; Yuet-Kin Leung
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-07       Impact factor: 4.741

Review 2.  Review of Prostate Anatomy and Embryology and the Etiology of Benign Prostatic Hyperplasia.

Authors:  LaTayia Aaron; Omar E Franco; Simon W Hayward
Journal:  Urol Clin North Am       Date:  2016-08       Impact factor: 2.241

3.  Histopathological classification criteria of rat model of chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Xianjin Wang; Shan Zhong; Tianyuan Xu; Leilei Xia; Xiaohua Zhang; Zhaowei Zhu; Minguang Zhang; Zhoujun Shen
Journal:  Int Urol Nephrol       Date:  2014-11-20       Impact factor: 2.370

4.  Impact of a folic acid-enriched diet on urinary tract function in mice treated with testosterone and estradiol.

Authors:  Kimberly P Keil; Lisa L Abler; Helene M Altmann; Zunyi Wang; Peiqing Wang; William A Ricke; Dale E Bjorling; Chad M Vezina
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-08

Review 5.  PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.

Authors:  Ming Jiang; Douglas W Strand; Omar E Franco; Peter E Clark; Simon W Hayward
Journal:  Differentiation       Date:  2011-06-08       Impact factor: 3.880

6.  Molecular mechanisms of bladder outlet obstruction in transgenic male mice overexpressing aromatase (Cyp19a1).

Authors:  Wei Lin; Nafis A Rahman; Jian Lin; Hua Zhang; Kemian Gou; Wanpeng Yu; Dahai Zhu; Ning Li; Ilpo Huhtaniemi; Xiangdong Li
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

7.  Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.

Authors:  Tristan M Nicholson; Priyanka D Sehgal; Sally A Drew; Wei Huang; William A Ricke
Journal:  Differentiation       Date:  2013-06-20       Impact factor: 3.880

8.  In Utero and Lactational TCDD Exposure Increases Susceptibility to Lower Urinary Tract Dysfunction in Adulthood.

Authors:  William A Ricke; Calvin W Lee; Tyler R Clapper; Andrew J Schneider; Robert W Moore; Kimberly P Keil; Lisa L Abler; Jalissa L Wynder; Arnaldo López Alvarado; Isaac Beaubrun; Jenny Vo; Tyler M Bauman; Emily A Ricke; Richard E Peterson; Chad M Vezina
Journal:  Toxicol Sci       Date:  2016-02-09       Impact factor: 4.849

9.  Preventive effects of oligomerized polyphenol on estradiol-induced prostatitis in rats.

Authors:  Dong Suk Kim; Eun Jin Lee; Kang Su Cho; So Jung Yoon; Young Hoon Lee; Sung Joon Hong
Journal:  Yonsei Med J       Date:  2009-06-23       Impact factor: 2.759

10.  Hyperestrogenism and low serum testosterone-17β-estradiol ratio are associated with non-bacterial male accessory gland inflammation.

Authors:  Rosita A Condorelli; Aldo E Calogero; Sandro La Vignera
Journal:  Int J Immunopathol Pharmacol       Date:  2016-04-18       Impact factor: 3.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.